Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“The external application of DOP (0.1–1 mM), the D1 agonist chloro-APB hydrobromide (CAPB, 50–100 μM) and the D2 agonist quinerolane ( QUI , 50–100 μM) induced a dose-dependent and reversible decline in the resting discharge frequency.”